Skip to main content
. 2015 Jul 30;6(36):39225–39234. doi: 10.18632/oncotarget.4407

Figure 8. Knockdown of miR-454 inhibited the growth of HepG2-engrafted tumors.

Figure 8

A. Representative tumors were photographed at 15 days after the first treatment with miR-454 inhibitor or control. B. Graph representing tumor volumes at the indicated days during the experiment for the two groups: control, miR-454 inhibitor. C. Tumor weight averages between control and miR-454 inhibitor-treated mice groups at the end of the experiment (day 25), Five mice in each group.